After a delay of several years, people living with multiple sclerosis in England will finally be able to get NHS access to fampridine, which has been shown to improve walking ability in trials. She added: "It's vital that MS services now have the support they need to make fampridine available to all people with MS who could benefit from it, regardless of where in England they live." It can be used in patients with any form of MS, but is only licensed to improve walking speed. It is estimated that around 5,000 people living with MS will be eligible in England in the first year. Aysen Slack, a 65-year-old from Eastbourne living with MS, was paying for fampridine privately for a while, but had to stop because of the cost.